| Status | Awaiting development |
| Technology type | Medicine |
| Decision | None selected |
| Process | STA Standard |
| ID number | 1575 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 09 April 2024 | Awaiting development. Following on from advice received from the company, timelines for this appraisal are to be confirmed whilst the company confirm their regulatory filing plans. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes. |
| 01 March 2024 | Please note that following on from conversations between NICE and the company, further information regarding the timelines for this appraisal will be available in due course. In the meantime, NICE will continue to monitor the situation and will provide an update as and when the situation changes. |
| 08 May 2019 | In progress. Referred 17 October 2018 |
For further information on our processes and methods, please see our CHTE processes and methods manual